BioCorRx Financials
| BICX Stock | USD 0.33 0.08 19.51% |
With this module, you can analyze BioCorRx financials for your investing period. You should be able to track the changes in BioCorRx individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
BioCorRx |
Understanding current and past BioCorRx Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BioCorRx's financial statements are interrelated, with each one affecting the others. For example, an increase in BioCorRx's assets may result in an increase in income on the income statement.
The data published in BioCorRx's official financial statements typically reflect BioCorRx's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving BioCorRx's quantitative information. For example, before you start analyzing numbers published by BioCorRx accountants, it's essential to understand BioCorRx's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Please note, the imprecision that can be found in BioCorRx's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BioCorRx. Check BioCorRx's Beneish M Score to see the likelihood of BioCorRx's management manipulating its earnings.
BioCorRx Stock Summary
BioCorRx competes with Guided Therapeutics, and Saker Aviation. BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. Biocorrx operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| ISIN | US09073C2052 |
| Business Address | 2390 East Orangewood |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Benchmark | Dow Jones Industrial |
| Website | www.biocorrx.com |
| Phone | 714 462 4880 |
| Currency | USD - US Dollar |
BioCorRx Key Financial Ratios
BioCorRx's financial ratios allow both analysts and investors to convert raw data from BioCorRx's financial statements into concise, actionable information that can be used to evaluate the performance of BioCorRx over time and compare it to other companies across industries.| Return On Asset | -2.52 | |||
| Target Price | 5.1 | |||
| Beta | 1.03 | |||
| Z Score | -87.5 |
BioCorRx Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioCorRx's current stock value. Our valuation model uses many indicators to compare BioCorRx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioCorRx competition to find correlations between indicators driving BioCorRx's intrinsic value. More Info.BioCorRx is number one stock in return on asset category among its peers. It also is number one stock in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value BioCorRx by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioCorRx's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.BioCorRx Systematic Risk
BioCorRx's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. BioCorRx volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on BioCorRx correlated with the market. If Beta is less than 0 BioCorRx generally moves in the opposite direction as compared to the market. If BioCorRx Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one BioCorRx is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of BioCorRx is generally in the same direction as the market. If Beta > 1 BioCorRx moves generally in the same direction as, but more than the movement of the benchmark.
BioCorRx February 26, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of BioCorRx help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BioCorRx. We use our internally-developed statistical techniques to arrive at the intrinsic value of BioCorRx based on widely used predictive technical indicators. In general, we focus on analyzing BioCorRx OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BioCorRx's daily price indicators and compare them against related drivers.
| Downside Deviation | 28.34 | |||
| Information Ratio | 0.0865 | |||
| Maximum Drawdown | 159.77 | |||
| Value At Risk | (27.08) | |||
| Potential Upside | 25.81 |
Additional Tools for BioCorRx OTC Stock Analysis
When running BioCorRx's price analysis, check to measure BioCorRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCorRx is operating at the current time. Most of BioCorRx's value examination focuses on studying past and present price action to predict the probability of BioCorRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCorRx's price. Additionally, you may evaluate how the addition of BioCorRx to your portfolios can decrease your overall portfolio volatility.